课题基金 / 基金详情

Enhance the willingness of healthcare workers to be vaccinated against COVID-19 in Germany

Enhance the willingness of healthcare workers to be vaccinated against COVID-19 in Germany
提高德国医护人员接种 COVID-19 疫苗的意愿
批准号:
466313237
负责人:
Professorin Dr. Nicole Skoetz
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
2021
资助国家:
德国
项目状态:
已结题
起止时间:
2020-12-31 至 2021-12-31

项目摘要

项目成果

Professorin Dr. Nicole Skoetz的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The approval of the first COVID-19 vaccine has been long-awaited in Germany to control the COVID-19 pandemic. Especially in nursing homes and hospitals, the vaccination could guarantee the safety of healthcare workers in contact with COVID-19 patients. The Willi-Vacc project aims to identify interventions to enhance the willingness of German healthcare workers to be vaccinated against COVID-19. The research objectives of Willi-Vacc are to:1. Scope the evidence on interventions to enhance willingness to be vaccinated against COVID-19 among the general population (Scoping Cochrane Review). We will start with a systematic scoping review to identify interventions to enhance willingness to be vaccinated against COVID-19 among the general population.2. Prioritise the interventions for their relevance to healthcare workers found in the scoping review together with stakeholders (Stakeholder meeting).Once the scoping review is finalised, we plan a stakeholder online meeting with representatives from the following groups:• Ständige Impfkommission (STIKO)• Robert Koch Institut (RKI)• World Health Organisation (WHO)• Bundeszentrale für gesundheitliche Aufklärung (BZgA)• Deutscher Berufsverband für Pflegeberufe (DBfK)• Deutscher Berufsverband für Altenpflege e.V (DBVA)• Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF)• Vaccination centers3. Conduct a living systematic review of the prioritised interventions (Cochrane Review).First, we will develop and publish a Cochrane protocol, outlining the inclusion and exclusion criteria and methods being used to conduct the living systematic review and the update. The final PICO questions will be determined based on the prioritisation process involving the stakeholders. If randomised controlled studies (RCTs) are available, we will include them. In case of insufficient RCT evidence, we will include prospectively planned controlled studies, if not available uncontrolled studies. The first version of the review will be published after nine months (planned as Cochrane Review). As we expect many new studies in this rapidly evolving field, an update after 12 months is planned.4. Discuss the implementation of the intervention strategies for healthcare workers in Germany with stakeholders (Stakeholder meeting).To implement the findings of the review and review updates in Germany we plan two further meetings with the stakeholder panel.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Assessment of the current state of the consideration of specific features of time-to-event analyses in meta-analyses: re-analysis of systematic reviews and implementation of guidance
海外基金